MIDOL COMPLETE (ACETAMINOPHEN/PYRILAMINE MALEATE/CAFFEINE)

Contraindicated



• dipyridamole

Severe



• Acid Reducer (cimetidine)
• Acid Relief (cimetidine)
• Adenocard
• Adenoscan
• adenosine
• adenosine (diagnostic)
• cimetidine
• Heartburn Relief
• Lexiscan
• regadenoson
• Tagamet Hb

Contraindicated



• 30 day risk period post-myocardial infarction
• Acetaminophen overdose
• Acute hepatic failure
• Acute hepatitis C

Severe



• Angle-closure glaucoma
• Benign prostatic hyperplasia
• Bladder outflow obstruction
• Chronic idiopathic constipation
• Disease of liver
• Necrotizing enterocolitis
• Peptic ulcer
• Protein-calorie malnutrition
• Severe renal impairment
• Shock
• Stenosing peptic ulcer
• Urinary retention

Contraindicated

Pyrilamine

Possible CNS excitation and seizure risk in newborns.

Do not use in pediatrics <6 years of age unless clinician consultation.

• 1 Day – 29 Days
• 1 Possible CNS excitation and seizure risk in newborns.
• 1 Do not use in pediatrics <6 years of age unless clinician consultation.
• 30 Days – 6 Years
• 1 Possible CNS excitation and seizure risk in newborns.
• 1 Do not use in pediatrics <6 years of age unless clinician consultation.

Severe Precaution

None

Management or Monitoring Precaution

Acetaminophen (oral,rectal)

Use weight based dosing in children less than 12 years.

Caution in: seizure disorder, cardiovascular disease, or in premature neonates with renal or hepatic impairment.

Adverse CNS effects of insomnia, restlessness, nervousness, and mild delirium, more severe in children.

• 1 Day – 12 Years
• Use weight based dosing in children less than 12 years.
• 1 Day – 364 Days
• Use weight based dosing in children less than 12 years.
• 1 Years – 13 Years
• Use weight based dosing in children less than 12 years.

Caffeine

Use weight based dosing in children less than 12 years.

Caution in: seizure disorder, cardiovascular disease, or in premature neonates with renal or hepatic impairment.

Adverse CNS effects of insomnia, restlessness, nervousness, and mild delirium, more severe in children.

• 1 Day – 12 Years
• Caution in: seizure disorder, cardiovascular disease, or in premature neonates with renal or hepatic impairment.
• Adverse CNS effects of insomnia, restlessness, nervousness, and mild delirium, more severe in children.
• 1 Day – 364 Days
• Caution in: seizure disorder, cardiovascular disease, or in premature neonates with renal or hepatic impairment.
• Adverse CNS effects of insomnia, restlessness, nervousness, and mild delirium, more severe in children.
• 1 Years – 13 Years
• Caution in: seizure disorder, cardiovascular disease, or in premature neonates with renal or hepatic impairment.
• Adverse CNS effects of insomnia, restlessness, nervousness, and mild delirium, more severe in children.